Psychedelic Legislation Tracker
Complete tracker of 255 psychedelic policy bills in 41 U.S. states, including decriminalization measures, regulated-access programs, and research authorizations. Status, sponsor, and latest action for every bill.
U.S. psychedelic legislation| Bill | State | Substance | Type | Status | Sponsor | Last action |
|---|
| SB43 - Provides relative to psychedelic-assisted therapy. (8/1/26) |
Louisiana |
Psilocybin |
Therapeutic Access |
Passed Legislature |
Patrick McMath |
Aug 1, 2026 |
| H4200 - Authorizing a pilot for the use of psychedelics in licensed treatment facilities |
Massachusetts |
Psilocybin |
Clinical Research |
In Committee |
James O'Day |
Jul 23, 2026 |
| H2203 - Establishing a pilot program for access to regulated psilocybin |
Massachusetts |
Psilocybin |
Clinical Research |
In Committee |
Marjorie Decker |
Jul 22, 2026 |
| HB1772 - Relative to prescribing ibogaine for investigational use only. |
New Hampshire |
Ibogaine |
Clinical Research |
Signed into Law |
Michael Moffett |
Jul 20, 2026 |
| H4986 - Relative to therapeutic psilocybin treatment centers |
Massachusetts |
Psilocybin |
Therapeutic Access |
Passed Committee |
Joint Committee on Public Health |
Jul 9, 2026 |
| SB1188 - Approved medications; scheduling; prescription authority |
Arizona |
Psilocybin |
Therapeutic Access |
Passed Legislature |
Thomas Shope |
Jun 22, 2026 |
| HB6020 - Health: research; participation in ibogaine clinical trials; provide for. Amends sec. 7212 of 1978 PA 368 (MCL 333.7212) & adds secs. 2222, 2222a & 2222b. |
Michigan |
Ibogaine |
Clinical Research |
In Committee |
Jaime Greene |
Jun 9, 2026 |
| HB1325 - Natural Medicine |
Colorado |
Psilocybin |
Therapeutic Access |
Passed Legislature |
Jarvis Caldwell |
Jun 4, 2026 |
| SB00191 - An Act Concerning The Psychedelic-assisted Therapy Pilot Program. |
Connecticut |
Psilocybin |
Clinical Research |
Passed Legislature |
Public Health Committee |
Jun 4, 2026 |
| SB2149 - AN ACT to amend Tennessee Code Annotated, Title 9; Title 33; Title 53; Title 63 and Title 68, relative to clinical trials. |
Tennessee |
Psilocybin |
Clinical Research |
Passed Legislature |
Page Walley |
May 27, 2026 |
| HB2075 - AN ACT to amend Tennessee Code Annotated, Title 9; Title 33; Title 53; Title 63 and Title 68, relative to clinical trials. |
Tennessee |
Psilocybin |
Clinical Research |
Passed Legislature |
Bryan Terry |
May 27, 2026 |
| SB2772 - PSILOCYBIN ADVISORY BOARD |
Illinois |
Psilocybin |
Clinical Research |
In Committee |
Rachel Ventura |
May 15, 2026 |
| AB2489 - Controlled substances: research. |
California |
Psilocybin |
Clinical Research |
In Committee |
Josh Lowenthal |
May 14, 2026 |
| HB717 - Medical Practice Act; regulation of the administration of psychedelic-assisted treatment and therapy; provide |
Georgia |
Psilocybin |
Therapeutic Access |
Signed into Law |
Sharon Cooper |
May 12, 2026 |
| HB3834 - Ibogaine clinical trials; Oklahoma Breakthrough Therapy Act; terms; requirements for drug developers; contractual terms; intellectual property rights; reports; intellectual property account; Office of the State Treasurer; adverse licensing action; effective date. |
Oklahoma |
Ibogaine |
Clinical Research |
Signed into Law |
Stan May |
May 12, 2026 |
| HB382 - Controlled substances; Schedule I; psilocybin; revise a provision |
Georgia |
Psilocybin |
Scheduling |
Signed into Law |
Ron Stephens |
May 11, 2026 |
| S05303 - Allows the growth, cultivation, and regulated adult use of psilocybin for the treatment of certain health conditions; provides for the certification of support service providers and the licensure of cultivators. |
New York |
Psilocybin |
Therapeutic Access |
In Committee |
Julia Salazar |
May 8, 2026 |
| A02142 - Allows the growth, cultivation, and regulated adult use of psilocybin for the treatment of certain health conditions; provides for the certification of support service providers and the licensure of cultivators. |
New York |
Psilocybin |
Therapeutic Access |
In Committee |
Amy Paulin |
May 8, 2026 |
| SB1767 - Modifies provisions relating to alternative therapies and treatments, including psilocybin |
Missouri |
Psilocybin |
Therapeutic Access |
Died |
Rick Brattin |
May 7, 2026 |
| HB2817 - Creates provisions relating to ibogaine treatment |
Missouri |
Ibogaine |
Therapeutic Access |
Passed Committee |
Matthew Overcast |
May 7, 2026 |
| HB1717 - Modifies provisions relating to alternative therapies and treatments, including psilocybin |
Missouri |
Psilocybin |
Therapeutic Access |
Passed Committee |
Richard West |
May 7, 2026 |
| HB1809 - Authorizing the medical use of psilocybin through a program established in the department of health and human services. |
New Hampshire |
Psilocybin |
Therapeutic Access |
Passed One Chamber |
Buzz Scherr |
May 7, 2026 |
| S1018 - The HEAL Act |
North Carolina |
Psilocybin |
Appropriations / Administrative |
Introduced |
Sophia Chitlik |
May 5, 2026 |
| HF978 - A bill for an act relating to the production and administration of psilocybin, and providing penalties. (Formerly HF 620.) |
Iowa |
Psilocybin |
Therapeutic Access |
In Committee |
Ways and Means |
May 1, 2026 |
| S01817 - Requires the office of addiction services and supports to encourage, aid, and facilitate clinical research into the use of ibogaine in drug treatment for heroin, methamphetamine and cocaine addiction. |
New York |
Ibogaine |
Clinical Research |
Died |
Nathalia Fernandez |
Apr 29, 2026 |
| SB3199 - Relating To Mental Health. |
Hawaii |
Psilocybin |
Clinical Research |
Passed One Chamber |
Chris Lee |
Apr 29, 2026 |
| HB427 - Task Force on Responsible Use of Natural Psychedelic Substances - Extension |
Maryland |
Psilocybin |
Therapeutic Access |
Signed into Law |
Pam Guzzone |
Apr 28, 2026 |
| SB336 - Task Force on Responsible Use of Natural Psychedelic Substances - Extension and Membership |
Maryland |
Psilocybin |
Therapeutic Access |
Signed into Law |
Brian Feldman |
Apr 28, 2026 |
| HF2906 - Psilocybin therapeutic use program established; protections for registered patients, designated cultivators, registered facilitators, and health care practitioners established; rulemaking authorized; civil actions authorized; fees established; advisory committee established; criminal penalties provided; and money appropriated. |
Minnesota |
Psilocybin |
Therapeutic Access |
Died |
Andrew Smith |
Apr 22, 2026 |
| SB031 - Use of Prescription Product with Controlled Substance |
Colorado |
Psilocybin |
Scheduling |
Passed Legislature |
William Lindstedt |
Apr 20, 2026 |
| SF3971 - Psilocybin therapeutic use program establishment |
Minnesota |
Psilocybin |
Therapeutic Access |
In Committee |
Clare Oumou Verbeten |
Apr 20, 2026 |
| LB795 - Designate bromazolam as a controlled substance under the Uniform Controlled Substances Act, correct the spelling of certain controlled substances, and enhance penalties for certain controlled substance offenses involving fentanyl |
Nebraska |
Psilocybin |
Therapeutic Access |
Signed into Law |
Barry DeKay |
Apr 17, 2026 |
| SB1682 - Modifies provisions relating to alternative therapies and treatments, including psilocybin |
Missouri |
Psilocybin |
Therapeutic Access |
Died |
Tracy McCreery |
Apr 16, 2026 |
| SB77 - AN ACT relating to ibogaine research in the Commonwealth. |
Kentucky |
Ibogaine |
Clinical Research |
Passed Legislature |
Donald Douglas |
Apr 14, 2026 |
| HF4577 - Psilocybin therapeutic use program established; protections for registered patients, registered suppliers, registered facilitators, and health care practitioners established; civil actions authorized; advisory committee established; and money appropriated. |
Minnesota |
Psilocybin |
Therapeutic Access |
In Committee |
Max Rymer |
Apr 9, 2026 |
| SB19 - AN ACT relating to mushrooms. |
Kentucky |
Psilocybin |
Therapeutic Access |
Passed Legislature |
Scott Madon |
Apr 9, 2026 |
| H7756 - Amends current law on controlled substances to permit psilocybin to be cultivated within a person's residence for personal use and contingent on the US FDA's program, mandate that RI department of health establish rules regulations. |
Rhode Island |
Psilocybin |
Trigger Law |
In Committee |
Brandon Potter |
Apr 9, 2026 |
| HB3263 - Definitions and general provisions; designating the morel mushroom as the state mushroom of Oklahoma; effective date. |
Oklahoma |
Psilocybin |
Therapeutic Access |
Passed Committee |
John George |
Apr 8, 2026 |
| HB1347 - Psilocybin; Board of Pharmacy to reschedule upon federal scheduling changes. |
Virginia |
Psilocybin |
Trigger Law |
Signed into Law |
Laura Jane Cohen |
Apr 6, 2026 |
| SB379 - Psilocybin; Board of Pharmacy to reschedule upon federal scheduling changes. |
Virginia |
Psilocybin |
Trigger Law |
Signed into Law |
Jennifer Boysko |
Apr 6, 2026 |
| SB1042 - Relating To Mental Health. |
Hawaii |
Psilocybin |
Clinical Research |
Passed One Chamber |
Chris Lee |
Apr 2, 2026 |
| H4050 - To amend the General Laws, in relation to promoting the health and well-being of the residents of the Commonwealth of Massachusetts by establishing a comprehensive framework supporting public health and safety through regulated adult use, support services, and cultivation of psilocybin-containing fungi; and providing for taxation and appropriation thereof |
Massachusetts |
Psilocybin |
Legalization |
In Committee |
Patrick Kearney |
Apr 2, 2026 |
| SB1581 - Establishes the "Veterans Mental Health Innovation Act" relating to ibogaine treatment |
Missouri |
Ibogaine |
Therapeutic Access |
Died |
Jason Bean |
Apr 1, 2026 |
| HB4626 - Relating to the establishment of a grant program to fund the United States Food and Drug Administration’s drug development trials with ibogaine |
West Virginia |
Ibogaine |
Therapeutic Access |
Vetoed |
Ryan Browning |
Apr 1, 2026 |
| H7916 - Provides for the authorized taking of mushrooms from lands under control of the DEM for personal use. |
Rhode Island |
Psilocybin |
Decriminalization |
In Committee |
David Place |
Mar 31, 2026 |
| HB2992 - HOPE PILOT PROGRAM |
Illinois |
Psilocybin |
Clinical Research |
In Committee |
Theresa Mah |
Mar 27, 2026 |
| HB1143 - ILLINOIS CURE ACT |
Illinois |
Psilocybin |
Scheduling |
In Committee |
LaShawn Ford |
Mar 27, 2026 |
| SB2184 - USE AND RESEARCH-ENTHEOGENS |
Illinois |
Psilocybin |
Scheduling |
In Committee |
Rachel Ventura |
Mar 27, 2026 |
| SB906 - Permitting lawful prescription of crystalline polymorph psilocybin under FDA recommendations |
West Virginia |
Psilocybin |
Scheduling |
Signed into Law |
Vince Deeds |
Mar 27, 2026 |
| H1726 - Relative to criminal disposition of limited psilocybin possession offenses |
Massachusetts |
Psilocybin |
Therapeutic Access |
In Committee |
Homar Gomez |
Mar 26, 2026 |
| H1624 - Establishing a task force to study equitable access to psilocybin and other entheogenic plants |
Massachusetts |
Psilocybin |
Legalization |
In Committee |
Mike Connolly |
Mar 26, 2026 |
| H1858 - Relative to removing criminal penalties for limited psilocybin possession |
Massachusetts |
Psilocybin |
Therapeutic Access |
In Committee |
Marc Lombardo |
Mar 26, 2026 |
| HB314 - Ibogaine; authorize SDH to select a consortium to conduct a drug development clinical trial with, to secure FDA's approval of. |
Mississippi |
Ibogaine |
Clinical Research |
Signed into Law |
Sam Creekmore |
Mar 26, 2026 |
| SB0083 - Controlled Substance Scheduling Amendments |
Utah |
Psilocybin |
Therapeutic Access |
Passed Legislature |
Evan Vickers |
Mar 24, 2026 |
| SCR171 - Urging The Convening Of A Mental Health Emerging Therapies Task Force To Prepare The State For The Integration Of Breakthrough Therapies And To Explore Opportunities To Expand Clinical Trials, Research Partnerships, And Treatment Capacity In The State. |
Hawaii |
Psilocybin |
Clinical Research |
In Committee |
Chris Lee |
Mar 19, 2026 |
| HB0390 - Veterans PTSD Clinical Research Amendments |
Utah |
Psilocybin |
Clinical Research |
Passed Legislature |
Jennifer Dailey-Provost |
Mar 19, 2026 |
| SR162 - Urging The Convening Of A Mental Health Emerging Therapies Task Force To Prepare The State For The Integration Of Breakthrough Therapies And To Explore Opportunities To Expand Clinical Trials, Research Partnerships, And Treatment Capacity In The State. |
Hawaii |
Psilocybin |
Clinical Research |
In Committee |
Chris Lee |
Mar 19, 2026 |
| SF4485 - Psilocybin therapeutic use program establishment |
Minnesota |
Psilocybin |
Therapeutic Access |
In Committee |
Mark Koran |
Mar 17, 2026 |
| H0899 - Adds to existing law to establish the Medical Advanced Healing Act. |
Idaho |
Psilocybin |
Therapeutic Access |
In Committee |
Health and Welfare Committee |
Mar 16, 2026 |
| SB2056 - Controlled substances; provide for automatic scheduling of certain substance if federal scheduling occurs. |
Mississippi |
Psilocybin |
Scheduling |
Signed into Law |
Angela Turner-Ford |
Mar 13, 2026 |
| HB1960 - Designates the smooth chanterelle as the official state mushroom |
Missouri |
Psilocybin |
Therapeutic Access |
Passed Committee |
Tara Peters |
Mar 12, 2026 |
| HB563 - Controlled substances; provide for automatic scheduling of psilocybin after federal scheduling. |
Mississippi |
Psilocybin |
Scheduling |
Died |
Sam Creekmore |
Mar 11, 2026 |
| HB1099 - Reschedule the pharmaceutical composition of crystalline polymorph psilocybin in a drug product approved by the Food and Drug Administration as a Schedule IV controlled substance. |
South Dakota |
Psilocybin |
Scheduling |
Passed Legislature |
Tom Pischke |
Mar 10, 2026 |
| SF4204 - Psilocybin regulation provisions |
Minnesota |
Psilocybin |
Regulation |
In Committee |
Clare Oumou Verbeten |
Mar 9, 2026 |
| SB1580 - Relating to compensation for journalism. |
Oregon |
Psilocybin |
Appropriations / Administrative |
Failed |
Khanh Pham |
Mar 6, 2026 |
| HB4110 - Relating to ibogaine; prescribing an effective date. |
Oregon |
Ibogaine |
Therapeutic Access |
Failed |
Alek Skarlatos |
Mar 6, 2026 |
| SB0114 - Controlled Substances Amendments |
Utah |
Psilocybin |
Therapeutic Access |
Failed |
Kirk Cullimore |
Mar 6, 2026 |
| HB1296 - Mental health; pilot program to support clinical research of certain veterans and first responders suffering from certain conditions; provide |
Georgia |
Psilocybin |
Clinical Research |
Passed One Chamber |
Martin Momtahan |
Mar 6, 2026 |
| LB877 - Designate certain substances as controlled substances under the Uniform Controlled Substances Act |
Nebraska |
Psilocybin |
Therapeutic Access |
Signed into Law |
Robert Hallstrom |
Mar 3, 2026 |
| H7925 - Amends current law on controlled substances to permit psilocybin to be cultivated within a person's residence for personal use and contingent on the Food and Drug Administration (FDA) program, mandates that RI DOH establishes rules regulations. |
Rhode Island |
Psilocybin |
Trigger Law |
In Committee |
Brandon Potter |
Feb 27, 2026 |
| SB0802 - Controlled substances: penalties; conduct associated with qualified psychoactive substances; exempt from criminal penalties in certain circumstances. Amends secs. 7401, 7403 & 7404 of 1978 PA 368 (MCL 333.7401 et seq.). |
Michigan |
Psilocybin |
Regulation |
In Committee |
Jeff Irwin |
Feb 26, 2026 |
| HB2961 - Creates provisions relating to ibogaine treatment |
Missouri |
Ibogaine |
Therapeutic Access |
Passed Committee |
Richard West |
Feb 26, 2026 |
| HB1643 - Modifies provisions relating to alternative therapies and treatments, including psilocybin |
Missouri |
Psilocybin |
Therapeutic Access |
Passed Committee |
Matthew Overcast |
Feb 26, 2026 |
| HB1803 - Appropriation; MDA to provide funding to Alcorn State for expansion of research and production of shiitake mushrooms. |
Mississippi |
Psilocybin |
Clinical Research |
Died |
Jeffery Harness |
Feb 25, 2026 |
| HB2218 - Amending the definition of "psilocybin" in the uniform controlled substances act to exclude the pharmaceutical composition of crystalline polymorph psilocybin and adding crystalline polymorph psilocybin to schedule IV of the uniformed controlled substance act. |
Kansas |
Psilocybin |
Scheduling |
In Committee |
Health and Human Services |
Feb 19, 2026 |
| HB5588 - Establish a regulated framework for the medical use of psilocybin to treat post-traumatic stress disorder (PTSD) |
West Virginia |
Psilocybin |
Therapeutic Access |
Died |
Rick Hillenbrand |
Feb 16, 2026 |
| HB1477 - Public Health - Ibogaine Clinical Research Grant Program - Establishment (Veterans Mental Health Innovations Act) |
Maryland |
Ibogaine |
Clinical Research |
Died |
Darrell Odom |
Feb 13, 2026 |
| HB4293 - Controlled dangerous substances; Veterans Mental Health Innovation Act; authorizing certain scientific research and clinical trials related to ibogaine; requiring registration; providing certain immunities; effective date. |
Oklahoma |
Ibogaine |
Clinical Research |
In Committee |
Daniel Pae |
Feb 10, 2026 |
| SB527 - Public Health - Ibogaine Clinical Research Grant Program - Establishment (Veterans Mental Health Innovations Act) |
Maryland |
Ibogaine |
Clinical Research |
Died |
Kevin Harris |
Feb 9, 2026 |
| SF2151 - A bill for an act removing psilocybin and psilocyn from the list of substances classified as schedule I controlled substances under Iowa's uniform controlled substances Act. |
Iowa |
Psilocybin |
Scheduling |
In Committee |
Doug Campbell |
Feb 5, 2026 |
| HB336 - Use Of Fda-approved Psilocybin |
New Mexico |
Psilocybin |
Scheduling |
Died |
Dayan Hochman-Vigil |
Feb 4, 2026 |
| SB5921 - Concerning psilocybin. |
Washington |
Psilocybin |
Therapeutic Access |
In Committee |
Jesse Salomon |
Feb 4, 2026 |
| SB2561 - Ibogaine; authorize MSDH to select a consortium to conduct a drug development clinical trial to secure FDA's approval of. |
Mississippi |
Ibogaine |
Clinical Research |
Died |
Josh Harkins |
Feb 3, 2026 |
| H0859 - An act relating to psychedelic therapy and clinical drug development trials |
Vermont |
Psilocybin |
Therapeutic Access |
In Committee |
Brian Cina |
Feb 3, 2026 |
| HB1796 - Allowing the use of psilocybin in approved clinical settings to treat qualified medical conditions. |
New Hampshire |
Psilocybin |
Therapeutic Access |
Died |
Michael Moffett |
Feb 3, 2026 |
| SB2562 - Mississippi Veterans PTSD Ibogaine Research Pilot Program; create. |
Mississippi |
Ibogaine |
Scheduling |
Died |
Jeff Tate |
Feb 3, 2026 |
| SB751 - Veterans and Former First Responders Research Pilot Program. |
California |
Psilocybin |
Clinical Research |
Failed |
Josh Becker |
Feb 2, 2026 |
| HB7091 - Expanding Veterans’ Access to Emerging Treatments Act |
Federal |
Psilocybin |
Clinical Research |
In Committee |
Jack Bergman |
Feb 2, 2026 |
| HB4640 - Relating to drugs and adding a provision relating to the scheduling of crystalline polymorph psilocybin approved by the Food and Drug Administration |
West Virginia |
Psilocybin |
Scheduling |
Died |
Evan Worrell |
Feb 2, 2026 |
| S1113 - Relative to removing criminal penalties for limited psilocybin possession |
Massachusetts |
Psilocybin |
Therapeutic Access |
In Committee |
Cindy Friedman |
Jan 29, 2026 |
| H2532 - Relative to therapeutic psilocybin treatment centers |
Massachusetts |
Psilocybin |
Clinical Research |
In Committee |
Lindsay Sabadosa |
Jan 28, 2026 |
| H2506 - Decriminalizing psilocybin as a treatment for PTSD and certain other conditions |
Massachusetts |
Psilocybin |
Therapeutic Access |
In Committee |
Steven Owens |
Jan 28, 2026 |
| HF2085 - A bill for an act relating to the production and administration of psilocybin and providing penalties. |
Iowa |
Psilocybin |
Therapeutic Access |
In Committee |
John Wills |
Jan 26, 2026 |
| SB1149 - Further providing for authority to control. |
Pennsylvania |
Psilocybin |
Therapeutic Access |
In Committee |
Tracy Pennycuick |
Jan 23, 2026 |
| HB4721 - Relating to drugs and adding a provision relating to the scheduling of crystalline polymorph psilocybin approved by the Food and Drug Administration |
West Virginia |
Psilocybin |
Scheduling |
Died |
Rick Hillenbrand |
Jan 22, 2026 |
| A09583 - Establishes a research grant program to fund clinical trials of ibogaine for the treatment of veterans for post-traumatic stress disorder; creates a fund to provide monies for the research grant program. |
New York |
Ibogaine |
Clinical Research |
In Committee |
Robert Smullen |
Jan 21, 2026 |
| S2283 - Establishes Psilocybin Behavioral Health Access and Therapy Pilot Program; appropriates $6 million. |
New Jersey |
Psilocybin |
Clinical Research |
Passed Legislature |
Nicholas Scutari |
Jan 20, 2026 |
| S3148 - "Psilocybin Behavioral Health Access and Services Act"; authorizes production and use of psilocybin to promote health and wellness. |
New Jersey |
Psilocybin |
Therapeutic Access |
Withdrawn |
Nicholas Scutari |
Jan 13, 2026 |
| A1526 - Establishes Psilocybin Behavioral Health Access and Therapy Pilot Program; appropriates $6 million. |
New Jersey |
Psilocybin |
Clinical Research |
Withdrawn |
Clinton Calabrese |
Jan 13, 2026 |
| A3852 - Establishes Psilocybin Behavioral Health Access and Therapy Pilot Program; appropriates $6 million. |
New Jersey |
Psilocybin |
Clinical Research |
Died |
Clinton Calabrese |
Jan 12, 2026 |
| HB1433 - Concerning access to psychedelic substances. |
Washington |
Psilocybin |
Therapeutic Access |
In Committee |
Nicole Macri |
Jan 12, 2026 |
| SB5201 - Concerning access to psychedelic substances. |
Washington |
Psilocybin |
Therapeutic Access |
In Committee |
Jesse Salomon |
Jan 12, 2026 |
| SB5204 - Concerning ibogaine-assisted therapy. |
Washington |
Ibogaine |
Therapeutic Access |
In Committee |
Jesse Salomon |
Jan 12, 2026 |
| S01801 - Establishes the psilocybin assisted therapy pilot program; provides such program will be offered to veterans and first responders from New York state; establishes a psilocybin assisted therapy pilot program fund. |
New York |
Psilocybin |
Clinical Research |
In Committee |
Nathalia Fernandez |
Jan 9, 2026 |
| A03845 - Establishes the psilocybin assisted therapy pilot program; provides such program will be offered to veterans and first responders from New York state; establishes a psilocybin assisted therapy pilot program fund. |
New York |
Psilocybin |
Clinical Research |
In Committee |
Patrick Burke |
Jan 8, 2026 |
| S00495 - Relates to medical use of psilocybin; establishes a psilocybin assisted therapy grant program; makes an appropriation therefor. |
New York |
Psilocybin |
Therapeutic Access |
In Committee |
Nathalia Fernandez |
Jan 7, 2026 |
| A00628 - Legalizes adult possession and use of certain natural plant or fungus-based hallucinogens; grants certain protections for individuals lawfully using such hallucinogens; removes such hallucinogens from the list of schedule I controlled substances; makes related provisions. |
New York |
Psilocybin |
Scheduling |
In Committee |
Linda Rosenthal |
Jan 7, 2026 |
| A03775 - Relates to medical use of psilocybin; establishes a psilocybin assisted therapy grant program; makes an appropriation therefor. |
New York |
Psilocybin |
Therapeutic Access |
In Committee |
Patrick Burke |
Jan 7, 2026 |
| S04664 - Directs the commissioner of health, in conjunction with the commissioners of mental health and veterans' services, to conduct a study on the use of ibogaine as a treatment for post-traumatic stress disorder, and the increasing rate of PTSD diagnoses in veterans and first responders. |
New York |
Ibogaine |
Therapeutic Access |
In Committee |
Jacob Ashby |
Jan 7, 2026 |
| A01522 - Requires the office of addiction services and supports to encourage, aid, and facilitate clinical research into the use of ibogaine in drug treatment for heroin, methamphetamine and cocaine addiction. |
New York |
Ibogaine |
Clinical Research |
In Committee |
David Weprin |
Jan 7, 2026 |
| HB1166 - Elections. |
Indiana |
Psilocybin |
Therapeutic Access |
In Committee |
Lorissa Sweet |
Jan 5, 2026 |
| S1400 - Authorizing a pilot for the use of psychedelics in licensed treatment facilities |
Massachusetts |
Psilocybin |
Therapeutic Access |
In Committee |
Cindy Friedman |
Oct 2, 2025 |
| HB3817 - Relating to ibogaine. |
Oregon |
Psilocybin |
Therapeutic Access |
Signed into Law |
|
Jun 27, 2025 |
| HB3817 - Relating to ibogaine. |
Oregon |
Ibogaine |
Therapeutic Access |
Failed |
Alek Skarlatos |
Jun 27, 2025 |
| SB14 - Relative to the penalty for certain fentanyl-related offenses; relative to establishing a mandatory minimum sentence for the crime of distribution of a controlled drug with death resulting; and relative to amending the penalties for the possession and use of a quantity of psilocybin for persons 18 years of age or older. |
New Hampshire |
Psilocybin |
Therapeutic Access |
Passed One Chamber |
William Gannon |
Jun 26, 2025 |
| HB4686 - Crimes: controlled substances; creating, manufacturing, possessing, or using psilocybin or psilocin; allow under certain circumstances. Amends 1978 PA 368 (MCL 333.1101 - 333.25211) by adding sec. 7404a. |
Michigan |
Psilocybin |
Therapeutic Access |
In Committee |
Mike McFall |
Jun 25, 2025 |
| HB2387 - Relating to psilocybin; and declaring an emergency. |
Oregon |
Psilocybin |
Therapeutic Access |
Signed into Law |
|
Jun 11, 2025 |
| HB2387 - Relating to psilocybin; and declaring an emergency. |
Oregon |
Psilocybin |
Therapeutic Access |
Passed Legislature |
Dacia Grayber |
Jun 11, 2025 |
| HF383 - A bill for an act relating to the controlled substance crystalline polymorph psilocybin. (Formerly HF 14.) Vetoed 6-11-25. |
Iowa |
Psilocybin |
Scheduling |
Vetoed |
Health And Human Services |
Jun 11, 2025 |
| SB2308 - Relating to the establishment of a consortium to conduct United States Food and Drug Administration's drug development clinical trials with ibogaine to secure the administration's approval of the medication's use for treatment of opioid use disorder, co-occurring substance use disorder, and any other neurological or mental health conditions for which ibogaine demonstrates efficacy and to the administration of that treatment. |
Texas |
Ibogaine |
Clinical Research |
Passed Legislature |
Tan Parker |
Jun 11, 2025 |
| SF659 - A bill for an act relating to state government and finances, including by making, modifying, limiting, or reducing appropriations, distributions, or transfers; authorizing expenditure of unappropriated moneys in special funds; providing for properly related matters including crystalline polymorph psilocybin, medical residency and fellowship positions, state membership in the Iowa individual health benefit reinsurance association, student abuse by school employees, modified supplemental amounts for school budgets, wagering taxes, a state fire marshal study, certain legislative interim studies, and 911 emergency communications services; making corrections; and including effective date, applicability, and retroactive applicability provisions. (Formerly SSB 1241.) Effective date: 06/11/2025, 07/01/2025. Applicability date: 01/01/2020, 04/30/2025, 07/01/2025. |
Iowa |
Psilocybin |
Scheduling |
Signed into Law |
Appropriations |
Jun 11, 2025 |
| LD1034 - An Act to Decriminalize Personal Possession of Therapeutic Amounts of Psilocybin for Adults |
Maine |
Psilocybin |
Therapeutic Access |
Failed |
Grayson Lookner |
Jun 10, 2025 |
| HB528 - Amending the penalties for the possession and use of psilocybin for persons 18 years of age or older. |
New Hampshire |
Psilocybin |
Therapeutic Access |
Passed One Chamber |
Kevin Verville |
Jun 5, 2025 |
| AB378 - Creates the Alternative Therapy Pilot Program. (BDR 40-820) |
Nevada |
Psilocybin |
Clinical Research |
Failed |
Max Carter |
Jun 3, 2025 |
| SJR10 - Urges Congress to take certain actions relating to the therapeutic use of certain psychedelic compounds. (BDR R-801) |
Nevada |
Psilocybin |
Therapeutic Access |
Passed Legislature |
Rochelle Nguyen |
Jun 1, 2025 |
| HB07065 - An Act Concerning The Decriminalization Of Possession Of Small Amounts Of Psilocybin. |
Connecticut |
Psilocybin |
Decriminalization |
Tabled |
Judiciary Committee |
May 20, 2025 |
| HB4014 - Relating to a study on the use of psychedelic therapies in the treatment of certain conditions. |
Texas |
Psilocybin |
Therapeutic Access |
In Committee |
John Bucy |
May 19, 2025 |
| HB951 - Modifies provisions relating to alternative therapies and treatments, including psilocybin |
Missouri |
Psilocybin |
Therapeutic Access |
Died |
Matthew Overcast |
May 15, 2025 |
| SSB1241 - A bill for an act relating to state government and finances, including by making, modifying, limiting, or reducing appropriations, distributions, or transfers, authorizing expenditure of unappropriated moneys in special funds, providing for properly related matters including crystalline polymorph psilocybin and medical residency and fellowship positions, making corrections, and including effective date and retroactive applicability provisions.(See SF 659.) |
Iowa |
Psilocybin |
Scheduling |
In Committee |
Appropriations |
May 14, 2025 |
| HB1439 - Further providing for authority to control. |
Pennsylvania |
Psilocybin |
Therapeutic Access |
In Committee |
Jennifer O'Mara |
May 12, 2025 |
| HB3717 - Relating to the establishment of a grant program to fund the United States Food and Drug Administration's drug development trials with ibogaine for the purpose of securing the administration's approval as a medication for treatment of opioid use disorder, co-occurring substance use disorder, and any other neurological or mental health conditions for which ibogaine demonstrates efficacy. |
Texas |
Ibogaine |
Therapeutic Access |
Passed Committee |
Cody Harris |
May 12, 2025 |
| HB2623 - Innovative Therapies Centers of Excellence Act of 2025 |
Federal |
Psilocybin |
Therapeutic Access |
In Committee |
Luis Correa |
May 8, 2025 |
| HB829 - Modifies provisions relating to alternative therapies and treatments, including psilocybin |
Missouri |
Psilocybin |
Therapeutic Access |
Passed Committee |
Richard West |
May 6, 2025 |
| SB3005 - Relating to a study on the use of psychedelic therapies in the treatment of certain conditions. |
Texas |
Psilocybin |
Therapeutic Access |
In Committee |
Cesar Blanco |
Apr 29, 2025 |
| HF620 - A bill for an act relating to the production of psilocybin and the administration of psilocybin to persons with post-traumatic stress disorder, and providing penalties.(See HF 978.) |
Iowa |
Psilocybin |
Therapeutic Access |
In Committee |
John Wills |
Apr 28, 2025 |
| HB07258 - An Act Concerning A Study Concerning Driving Under The Influence Of Cannabis Or Psilocybin. |
Connecticut |
Psilocybin |
Regulation |
Tabled |
Judiciary Committee |
Apr 23, 2025 |
| SB242 - Revises provisions relating to the sale of residential property. (BDR 10-328) |
Nevada |
Psilocybin |
Therapeutic Access |
Failed |
Edgar Flores |
Apr 12, 2025 |
| HB3344 - Relating to the establishment of a grant program to fund the United States Food and Drug Administration’s drug development trials with ibogaine |
West Virginia |
Ibogaine |
Therapeutic Access |
Passed Committee |
Evan Worrell |
Apr 11, 2025 |
| SB219 - Medical Psilocybin Act |
New Mexico |
Psilocybin |
Therapeutic Access |
Signed into Law |
Craig Brandt |
Apr 7, 2025 |
| SB1135 - Crystalline polymorph psilocybin; regulations for prescribing, etc. |
Virginia |
Psilocybin |
Scheduling |
Vetoed |
Jennifer Boysko |
Apr 2, 2025 |
| HB1091 - Designation of State Mushroom |
Colorado |
Psilocybin |
Therapeutic Access |
Passed Legislature |
Jacque Phillips |
Mar 31, 2025 |
| HB1063 - FDA-Approved Crystalline Polymorph Psilocybin Use |
Colorado |
Psilocybin |
Scheduling |
Passed Legislature |
Kyle Brown |
Mar 31, 2025 |
| SB2064 - The scheduling of controlled substances; and to declare an emergency. |
North Dakota |
Psilocybin |
Scheduling |
Signed into Law |
Judiciary |
Mar 27, 2025 |
| HB3343 - Relating to drugs and adding a provision relating to the scheduling of crystalline polymorph psilocybin approved by the Food and Drug Administration |
West Virginia |
Psilocybin |
Scheduling |
Passed One Chamber |
Evan Worrell |
Mar 27, 2025 |
| S568 - Innovative Treatments for Mental Health Act |
North Carolina |
Psilocybin |
Therapeutic Access |
Died |
Sophia Chitlik |
Mar 26, 2025 |
| HF2699 - Psilocybin cultivation, possession, transportation, and personal use by individuals 21 years of age or older authorized; protections established; public education and harm reduction programs established; Psychedelic Medicine Board established; criminal penalties provided; rulemaking authorized; civil actions authorized; and money appropriated. |
Minnesota |
Psilocybin |
Decriminalization |
In Committee |
Andrew Smith |
Mar 24, 2025 |
| HM58 - Study Psilocybin-based Medication Treatment |
New Mexico |
Psilocybin |
Therapeutic Access |
Died |
Dayan Hochman-Vigil |
Mar 14, 2025 |
| SB90 - Modifies provisions relating to alternative therapies and treatments, including psilocybin |
Missouri |
Psilocybin |
Therapeutic Access |
Died |
Stephen Webber |
Mar 12, 2025 |
| S0106 - An act relating to continuing the Psychedelic Therapy Advisory Working Group |
Vermont |
Psilocybin |
Therapeutic Access |
In Committee |
Martine Gulick |
Mar 11, 2025 |
| H0452 - An act relating to decriminalization of psilocybin-containing mushrooms and the establishment of the Psilocybin Therapeutic Consultation Program |
Vermont |
Psilocybin |
Therapeutic Access |
In Committee |
Brian Cina |
Feb 28, 2025 |
Psychedelic legislation by state